Primary Membranous Nephropathy Clinical Trials

38 clinical trials for Primary Membranous Nephropathy across international registries, including 17 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease — RECRUITING · PHASE2
• A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN) — RECRUITING · PHASE3
• Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN) — RECRUITING · PHASE2
• Study of WAL0921 in Patients With Glomerular Kidney Diseases — RECRUITING · PHASE2
• A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy — RECRUITING · PHASE2
• A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy — RECRUITING · PHASE3
• Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN) — RECRUITING · PHASE2
• A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) — RECRUITING · PHASE1
• A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy. — RECRUITING · PHASE2
• A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy — RECRUITING · PHASE1
• Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy — RECRUITING · PHASE4
• Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy — RECRUITING · PHASE2
• OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study) — RECRUITING · PHASE3
• Study of YK012 in Primary Membranous Nephropathy — RECRUITING · PHASE1
• A Real World Study About PMN — RECRUITING
• AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF FELZARTAMAB IN PARTICIPANTS WITH PRIMARY MEMBRANOUS NEPHROPATHY (PMN) [PROMINENT] — RECRUITING · PHASE3
• Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy — RECRUITING · PHASE4
• A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous Nephropathy — NOT_YET_RECRUITING · PHASE1
• Universal STAR-T Cell Injection in Autoimmune Kidney Diseases — NOT_YET_RECRUITING · NA
• Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001 — COMPLETED · PHASE1
• Phase II Clinical Study on the Efficacy and Safety of QLS7305 in Patients With Kidney Disease (Part A) — NOT_YET_RECRUITING · PHASE2
• A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy — ACTIVE_NOT_RECRUITING · PHASE2
• A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy — ACTIVE_NOT_RECRUITING · PHASE3
• A PHASE 3 RANDOMIZED, OPEN-LABEL MULTICENTER STUDY TO EVALUATE EFFICACY AND SAFETY OF INEBILIZUMAB IN ADULT PARTICIPANTS WITH PRIMARY MEMBRANOUS NEPHROPATHY (PMN) — NOT_YET_RECRUITING · PHASE3
• A Phase 2b/3 Adaptive, Randomized, Active controlled Study Evaluating the Efficacy, Safety, and Tolerability of Povetacicept Versus Calcineurin Inhibitor in the Treatment of Primary Membranous Nephropathy — TERMINATED · PHASE3
• A Phase III, Randomized, Open-Label Active Comparator-Controlled Multicenter Study to Evaluate Efficacy and Safety of Obinutuzumab in Patients with Primary Membranous Nephropathy — TERMINATED · PHASE3
• A Phase I Study of YK012 in Primary Membranous Nephropathy — NOT_YET_RECRUITING · PHASE1
• REmission in Membranous Nephropathy International Trial (REMIT) — WITHDRAWN · PHASE3
• A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy — ACTIVE_NOT_RECRUITING · PHASE2
• A Phase Ib/ Ⅱ Clinical Study of MIL62 in Primary Membranous Nephropathy — COMPLETED · PHASE1
• A Phase Ⅲ Clinical Study of MIL62 in Primary Membranous Nephropathy — ACTIVE_NOT_RECRUITING · PHASE3
• Obinutuzumab induced decreases of PLA2Rab in MN: a pilot study — NOT_YET_RECRUITING · PHASE2
• A Study to Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous Nephropathy — NOT_YET_RECRUITING · PHASE2
• Optimization of a Decision Formula for Optimal Timing of Immunosuppressive Therapy Initiation in Primary Membranous Nephropathy: A Multicenter Retrospective Cohort Study — ACTIVE_NOT_RECRUITING
• Obinutuzumab for primary membranous nephropathy: a pilot study in patients with rituximab-resistant or rituximab-dependent nephrotic syndrome and in patients intolerant to rituximab (the ORION study) — OTHER · PHASE2
• The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy — NOT_YET_RECRUITING · PHASE2
• Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy — OTHER · PHASE2
• A PHASE 2/3, MULTICENTER, RANDOMIZED, ACTIVE-CONTROLLED, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ZANUBRUTINIB IN PATIENTS WITH PRIMARY MEMBRANOUS NEPHROPATHY — NOT_YET_RECRUITING · PHASE2

Refine this search